Johnson & Johnson (J&J) recently announced a significant shift in their approach to the 340B drug discount program, aiming to change how discounts are offered for crucial medications. This policy adjustment is set to take effect on October 15, 2024, and has raised considerable concerns among
The Democratic National Convention (DNC) set the stage for critical discussions on the current U.S. political and health landscape. The event focused on the healthcare policies of Vice President Kamala Harris and her running mate, Minnesota Governor Tim Walz. Additionally, the convention addressed
The healthcare industry is always evolving, driven by the need to improve patient care, reduce costs, and enhance operational efficiency. One of the most revolutionary technologies gaining traction in this sector is blockchain. Originally associated with cryptocurrencies, blockchain is now emerging
CluePoints, a standout innovator in the pharmaceutical and healthcare sectors, is spearheading significant changes through advancements in Risk-Based Quality Management (RBQM) and centralized monitoring. This article delves into various facets of these developments, drawing insights from Francois
In a significant move poised to revolutionize the pharmaceutical supply chain, LSPedia, a leader in SaaS solutions for global product traceability, has announced a strategic partnership with Pharma Logistics, a front-runner in pharmaceutical reverse distribution. This collaboration promises to set
The pharmaceutical industry plays a crucial role in developing medications that save and improve lives. This sector is characterized by a complex interplay of market forces, regulatory frameworks, and legal precedents that impact competition, pricing, and access to medicines. Understanding how
